Uniwersytet Jagiellonski Collegium Medicum — Sponsor Intelligence | 8 EU Trials

Filter these 8 trials by condition, phase, country and more.

Open in Search →

8 Registered trials

3 Recruiting

5 Completed trials

1 Countries active

5 Unique IMPs

100% Results reported

Phase III

Phase II/III

Phase III: 5 Phase II/III: 3

100%

5 of 5 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Anal fistula 1 Breast cancer 1

Top IMPs

ACETYLSALICYLIC ACID 1 DINUTUXIMAB BETA 1 IVABRADINE 1 MONTELUKAST 1 NOREPINEPHRINE 1

All trials

8 total

A clinical study is aimed at comparing the effectiveness of two types of cell therapy in treating anal fistulas associated with Crohn's dise… Recruiting

2024-518898-34-00 Phase II/III 1 country
The effect of noradrenaline infusion versus standard blood pressure management on perioperative HYPotension in NOncaRdiac surgery. Recruiting

2023-508255-39-00 Phase III 1 country NOREPINEPHRINE
Iodine Contrasts Effectiveness and Safety in Contrast Enhanced Mammography and breast magnetic resonance imaging. Recruiting

2023-507644-37-00 Phase III 1 country
Immunotherapy with dinutuximab beta in combination with chemotherapy for the treatment of patients with primary neuroblastoma refractory to … Ended

2024-513141-37-00 Phase III 1 country DINUTUXIMAB BETA
Ivabradine for PREVENTion of Myocardial Injury after Noncardiac Surgery (MINS) - PREVENT-MINS Trial Ended

2024-515226-81-00 Phase III 1 country IVABRADINE
The assessment of cysteinyl leukotriene receptor antagonist role in inhibition of atherosclerosis, proliferation and its influence on endoth… Ended

2024-511894-32-00 Phase III 1 country MONTELUKAST
Long-term aspirin therapy as a predictor of decreased susceptibility to SARSCoV-2 infection in aspirin-exacerbated respiratory disease Ended

2024-514602-31-00 Phase II/III 1 country ACETYLSALICYLIC ACID
Preoperative intraperitoneal chemotherapy in adjuvant hyperthermia adjunctive therapy in advanced gastric cancer with high-risk of peritonea… Ended

2024-516042-18-00 Phase II/III 1 country

Showing 1–8 of 8 trials

← All sponsors A–Z